Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MindBio has appointed Venture Liquidity Providers Inc to initiate its market making service to provide assistance in maintaining an orderly trading market
-
SOUTH SAN FRANCISCO, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced the pricing of an underwritten public offering of 87,500,000 shares of its...
-
SHANGHAI, April 15, 2026 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T-cell engagers, is pleased...
-
True Cellular Formulas details Zinc7's seven-form zinc complex, ingredient structure, and multi-form zinc bioavailability for women over 40.
-
Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
-
Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Combined company to operate as Obsidian Therapeutics, Inc. and to advance Obsidian’s pipeline of novel engineered TIL cell therapies for the treatment of patients with solid tumors.Obsidian’s lead...
-
New York, USA, April 14, 2026 (GLOBE NEWSWIRE) -- The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight The psoriasis clinical trial...
-
CHARLOTTE, N.C., April 14, 2026 (GLOBE NEWSWIRE) -- MD&M South, the premier event for medical device manufacturing and healthcare innovation, is proud to announce collaboration with an extensive...
-
Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Enzymatic Deoxyribonucleic Acid (DNA) Synthesis Technology Market Report 2026" has been added to ResearchAndMarkets.com's offering. The enzymatic...